P/B
13
MindWalk
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
$64.1M
Market Cap • 9/18/2026
1983
(43 years)
Founded
2010
(16 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
5,5
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,1
EPS
—
Market Cap
Market Cap
64,1M
EV
61,1M
EV/Revenue
5,2
EV/EBITDA
-5,3
EV/EBIT
-5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-1,7%
Total Yield
-1,7%
Dividend Yield 5Y
0%
Payout
0%
Retained Earnings
-106,2M
Profitability
Gross Margin
60,8%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
32,6%
Capex/Revenue
1,2%
Capex/D&A
21%
Capex/OCF
-1,6%
SBC/OCF
—
% PPE
23,1%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-5%
CAGR Op. Income 5Y
8,5%
CAGR Net Income 5Y
8,8%
CAGR EPS 5Y
-10,8%
CAGR OCF 5Y
41,9%
Leverage
N.D./EBITDA
0,3
Debt/Equity
0%
Current Ratio
1,8
Quick Ratio
1,6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!